 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Research > Ciphergen Biosystems, Inc.
 |
Ciphergen Biosystems, Inc. |
 |
 |
 |
PROFILE |
 |
Ciphergen Biosystems is helping make the next step in biotechnology -- deciphering proteins. The company focuses on proteomics, or protein-based research. Its ProteinChip System includes disposable ProteinChip arrays, a chip reader, and software that allow biologists and drug developers to discover new protein biomarkers and to identify protein function by connecting DNA and protein research. The system can also analyze protein interactions. Customers include Amgen, Human Genome Sciences, and Merck. Ciphergen is also setting up Biomarker Discovery Centers, supplementing its facilities in California, Pennsylvania, and Denmark. Investors in the company include Atlas Venture and laboratory services provider MDS.
COMPETITION |
 |
APBiotech Inc (dossier)
Applied Biosystems Group (ABI)
QIAGEN N.V. (QGENF)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 8.90
1-Yr. Sales Growth: 77.6%
Employees: 114
Revenue per employee: $78,070.18
KEY PEOPLE |
 |
William E. Rich
CEO
Matthew Hogan
CFO
CONTACT INFO |
 |
6611 Dumbarton Circle
Fremont, CA 94555
US
Phone: 510-505-2100
Fax: 510-505-2101
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |